# Dyne Therapeutics, Inc.: filings

DYN · Nasdaq · CIK 1818794 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dyn.md) · [Financials](/companies/dyn/financials.md) · [Filings](/companies/dyn/filings.md) · [Insiders](/companies/dyn/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 329, 144 207, 8-K 65, 3 29, SC 13G/A 24, SCHEDULE 13G/A 21, 10-Q 18, SC 13G 16, 424B5 11, S-8 10, CORRESP 7, 10-K 6, DEF 14A 6, DEFA14A 6, ARS 4, UPLOAD 4, EFFECT 3, SCHEDULE 13G 3, 424B4 2, 4/A 2, DRS 2, S-1 2, S-1MEF 2, 3/A 1, 8-A12B 1, CERT 1, D 1, PRE 14A 1, S-1/A 1, S-3 1, S-3ASR 1, S-3MEF 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 20:10 ET | [8-K](/filings/0001818794-26-000009.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001818794-26-000009 |
| 2026-07-29 | 20:35 ET | [8-K](/filings/0001193125-26-323940.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323940 |
| 2026-07-29 | 20:05 ET | [10-Q](/filings/0001193125-26-323639.md) | Quarterly report, period 2026-06-30 | 0001193125-26-323639 |
| 2026-07-22 | 21:19 ET | [8-K](/filings/0001193125-26-312571.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-312571 |
| 2026-07-20 | 11:35 ET | [8-K](/filings/0001193125-26-308343.md) | 8.01 Other events | 0001193125-26-308343 |
| 2026-06-22 | 20:15 ET | [8-K](/filings/0001818794-26-000005.md) | 5.02 Departure or appointment of officers or directors | 0001818794-26-000005 |
| 2026-06-17 | 11:35 ET | [8-K](/filings/0001818794-26-000003.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001818794-26-000003 |
| 2026-06-08 | 20:05 ET | [8-K](/filings/0001193125-26-261696.md) | 5.07 Shareholder vote results | 0001193125-26-261696 |
| 2026-06-03 | 11:35 ET | [8-K](/filings/0001193125-26-254597.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-254597 |
| 2026-05-11 | 11:35 ET | [8-K](/filings/0001193125-26-215720.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-215720 |
| 2026-05-11 | 11:25 ET | [10-Q](/filings/0001193125-26-215702.md) | Quarterly report, period 2026-03-31 | 0001193125-26-215702 |
| 2026-04-23 | 20:05 ET | [DEF 14A](/filings/0001193125-26-173655.md) | Proxy statement, period 2026-04-22 | 0001193125-26-173655 |
| 2026-03-02 | 12:35 ET | [8-K](/filings/0001193125-26-084207.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-084207 |
| 2026-03-02 | 12:20 ET | [10-K](/filings/0001193125-26-084178.md) | Annual report, period 2025-12-31 | 0001193125-26-084178 |
| 2026-01-12 | 12:35 ET | [8-K](/filings/0001193125-26-009782.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009782 |
| 2025-12-23 | 12:35 ET | [8-K](/filings/0001193125-25-329511.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-329511 |
| 2025-12-10 | 21:22 ET | [8-K](/filings/0001193125-25-314249.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314249 |
| 2025-12-08 | 21:07 ET | [8-K](/filings/0001193125-25-311221.md) | 2.03 New direct financial obligation | 0001193125-25-311221 |
| 2025-12-08 | 11:36 ET | [8-K](/filings/0001193125-25-310516.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310516 |
| 2025-11-05 | 21:16 ET | [8-K](/filings/0001193125-25-266979.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266979 |
| 2025-11-05 | 21:05 ET | [10-Q](/filings/0001193125-25-266882.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266882 |
| 2025-10-02 | 20:10 ET | [8-K](/filings/0001193125-25-228317.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-228317 |
| 2025-08-04 | 11:35 ET | [8-K](/filings/0000950170-25-101620.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0000950170-25-101620 |
| 2025-07-28 | 20:15 ET | [8-K](/filings/0000950170-25-099184.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099184 |
| 2025-07-28 | 20:08 ET | [10-Q](/filings/0000950170-25-099161.md) | Quarterly report, period 2025-06-30 | 0000950170-25-099161 |
| 2025-07-01 | 20:40 ET | [8-K](/filings/0001193125-25-154057.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-154057 |
| 2025-06-30 | 20:01 ET | [8-K](/filings/0001193125-25-152652.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-152652 |
| 2025-06-17 | 11:04 ET | [8-K](/filings/0001193125-25-141739.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-141739 |
| 2025-06-05 | 20:09 ET | [8-K](/filings/0000950170-25-082317.md) | 5.07 Shareholder vote results | 0000950170-25-082317 |
| 2025-05-08 | 11:35 ET | [8-K](/filings/0000950170-25-066396.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066396 |
| 2025-05-08 | 11:25 ET | [10-Q](/filings/0000950170-25-066386.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066386 |
| 2025-04-15 | 11:34 ET | [DEF 14A](/filings/0000950170-25-053950.md) | Proxy statement, period 2025-05-30 | 0000950170-25-053950 |
| 2025-03-20 | 20:08 ET | [8-K](/filings/0001193125-25-058979.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-058979 |
| 2025-02-27 | 12:35 ET | [8-K](/filings/0000950170-25-028369.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028369 |
| 2025-02-27 | 12:20 ET | [10-K](/filings/0000950170-25-028356.md) | Annual report, period 2024-12-31 | 0000950170-25-028356 |
| 2025-01-10 | 11:56 ET | [8-K](/filings/0001193125-25-004057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-004057 |
| 2024-11-12 | 14:20 ET | [8-K](/filings/0001193125-24-255269.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-255269 |
| 2024-11-12 | 12:35 ET | [8-K](/filings/0000950170-24-124583.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124583 |
| 2024-11-12 | 12:25 ET | [10-Q](/filings/0000950170-24-124572.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124572 |
| 2024-09-03 | 11:16 ET | [8-K](/filings/0001193125-24-211534.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-211534 |
| 2024-08-12 | 21:15 ET | [8-K](/filings/0000950170-24-095537.md) | 2.02 Results of operations | 0000950170-24-095537 |
| 2024-08-12 | 21:05 ET | [10-Q](/filings/0000950170-24-095527.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095527 |
| 2024-05-24 | 21:00 ET | [8-K](/filings/0000950170-24-064700.md) | 5.07 Shareholder vote results | 0000950170-24-064700 |
| 2024-05-22 | 11:59 ET | [8-K](/filings/0001193125-24-144470.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-144470 |
| 2024-05-20 | 11:37 ET | [8-K](/filings/0001193125-24-142232.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-142232 |
| 2024-05-02 | 20:15 ET | [8-K](/filings/0000950170-24-052142.md) | 2.02 Results of operations | 0000950170-24-052142 |
| 2024-05-02 | 20:05 ET | [10-Q](/filings/0000950170-24-052066.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052066 |
| 2024-04-05 | 20:15 ET | [DEF 14A](/filings/0000950170-24-042276.md) | Proxy statement, period 2024-05-22 | 0000950170-24-042276 |
| 2024-03-25 | 11:39 ET | [8-K](/filings/0001193125-24-075932.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-075932 |
| 2024-03-05 | 12:41 ET | [8-K](/filings/0000950170-24-025408.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-025408 |

Page 1 of 2. [Older](/companies/dyn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.